🇨🇦 Fluzone Quadrivalent vaccine, 2018-2019 formulation in Canada

Fluzone Quadrivalent vaccine, 2018-2019 formulation (Fluzone Quadrivalent vaccine, 2018-2019 formulation) regulatory status in Canada.

Marketing authorisation

Fluzone Quadrivalent vaccine, 2018-2019 formulation in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Fluzone Quadrivalent vaccine, 2018-2019 formulation approved in Canada?

Yes. Health Canada has authorised it.

Who is the marketing authorisation holder for Fluzone Quadrivalent vaccine, 2018-2019 formulation in Canada?

Sanofi Pasteur, a Sanofi Company is the originator. The local marketing authorisation holder may differ — check the official source linked above.